Annual Report

Overview

The report describes the FDA's May 2019 re-inspection as closed out, with IDT's facility classification restored to Voluntary Action Indicated. It highlights the company's first medicinal cannabis manufacturing permit, granted in August 2019, and the related expansion strategy. Financially, reported revenue was 12,130 $000 and the company recorded a $6.083 million loss after tax.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2019
Period: Ends 30 June 2019
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services